LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

Search

West Pharmaceutical Services Inc

Closed

SectorHealthcare

276.44 0.57

Overview

Share price change

24h

Current

Min

275.5

Max

277.64

Key metrics

By Trading Economics

Income

8.2M

140M

Sales

38M

804M

P/E

Sector Avg

40.664

78.892

EPS

1.96

Dividend yield

0.31

Profit margin

17.406

Employees

10,600

EBITDA

19M

217M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.66% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.31%

2.38%

Next Dividend date

4 Feb 2026

Next Ex Dividend date

28 Jan 2026

Market Stats

By TradingEconomics

Market Cap

9.2M

20B

Previous open

275.87

Previous close

276.44

News Sentiment

By Acuity

34%

66%

83 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Dec 2025, 21:41 UTC

Acquisitions, Mergers, Takeovers

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 Dec 2025, 14:57 UTC

Acquisitions, Mergers, Takeovers

Accenture to Acquire Cabel Industry from Fibonacci Group

25 Dec 2025, 23:42 UTC

Market Talk

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 Dec 2025, 23:40 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 Dec 2025, 00:20 UTC

Acquisitions, Mergers, Takeovers

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 Dec 2025, 22:22 UTC

Acquisitions, Mergers, Takeovers

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 Dec 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 Dec 2025, 19:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 Dec 2025, 19:35 UTC

Market Talk

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 Dec 2025, 19:09 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

24 Dec 2025, 19:09 UTC

Market Talk
Acquisitions, Mergers, Takeovers

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 Dec 2025, 19:06 UTC

Market Talk

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 Dec 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 Dec 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

24 Dec 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 Dec 2025, 17:08 UTC

Acquisitions, Mergers, Takeovers

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 Dec 2025, 16:53 UTC

Acquisitions, Mergers, Takeovers

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 Dec 2025, 16:31 UTC

Market Talk
Acquisitions, Mergers, Takeovers

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 Dec 2025, 16:28 UTC

Acquisitions, Mergers, Takeovers

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 Dec 2025, 16:17 UTC

Market Talk

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 Dec 2025, 15:33 UTC

Acquisitions, Mergers, Takeovers

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 Dec 2025, 15:30 UTC

Acquisitions, Mergers, Takeovers

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 Dec 2025, 15:19 UTC

Acquisitions, Mergers, Takeovers

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 Dec 2025, 14:49 UTC

Acquisitions, Mergers, Takeovers

Mexico's Ollamani Sells Stake in Azteca Stadium

24 Dec 2025, 14:19 UTC

Market Talk

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 Dec 2025, 14:08 UTC

Acquisitions, Mergers, Takeovers

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 Dec 2025, 14:06 UTC

Market Talk

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 Dec 2025, 13:24 UTC

Market Talk

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 Dec 2025, 12:59 UTC

Acquisitions, Mergers, Takeovers

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 Dec 2025, 12:51 UTC

Acquisitions, Mergers, Takeovers

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

25.66% upside

12 Months Forecast

Average 348.7 USD  25.66%

High 375 USD

Low 285 USD

Based on 12 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

83 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat